Chemours Adds Directors, Updates Executive Pay

Ticker: CC · Form: 8-K · Filed: 2024-03-25T00:00:00.000Z

Sentiment: neutral

Topics: governance, board-of-directors, executive-compensation

Related Tickers: CC

TL;DR

Chemours adds 2 new directors to the board, effective March 21st.

AI Summary

On March 22, 2024, The Chemours Company filed an 8-K report detailing changes in its board of directors and executive compensation. Specifically, the company announced the election of two new directors, Ms. Dawn R. Reardon and Mr. David A. Schanzer, to its Board of Directors, effective March 21, 2024. The filing also disclosed updates to the compensatory arrangements for certain officers.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: low — This filing primarily concerns routine corporate governance changes like director appointments and executive compensation updates, which typically carry low immediate risk.

Key Players & Entities

FAQ

Who are the newly elected directors to The Chemours Company's Board?

Ms. Dawn R. Reardon and Mr. David A. Schanzer were elected as new directors.

When were the new directors' appointments effective?

The appointments of Ms. Dawn R. Reardon and Mr. David A. Schanzer were effective March 21, 2024.

What type of corporate event is reported in this 8-K filing?

This 8-K reports on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.

What is the principal executive office address for The Chemours Company?

The principal executive offices are located at 1007 Market Street, Wilmington, Delaware 19801.

What is the Commission File Number for The Chemours Company?

The Commission File Number for The Chemours Company is 001-36794.

From the Filing

0001193125-24-075860.txt : 20240325 0001193125-24-075860.hdr.sgml : 20240325 20240325060404 ACCESSION NUMBER: 0001193125-24-075860 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20240322 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240325 DATE AS OF CHANGE: 20240325 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 24776803 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 773 1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 8-K 1 d814363d8k.htm 8-K 8-K Chemours Co false 0001627223 0001627223 2024-03-22 2024-03-22     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 22, 2024 Date of Report (Date of Earliest Event Reported)     The Chemours Company (Exact Name of Registrant as Specified in Its Charter)       Delaware   001-36794   46-4845564 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.) 1007 Market Street Wilmington , Delaware 19801 (Address of principal executive offices) Registrant’s telephone number, including area code: (302) 773-1000     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of Each Class   Trading Symbol(s)   Name of Exchange on Which Registered Common Stock ($0.01 par value)   CC   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. The Board of Directors (the “Board”) of The Chemours Company (the “Company”) has named Denise Dignam, formerly Interim Chief Executive Officer, as President and Chief Executive Officer and as a member of the Board, effective as of March 22, 2024. Ms. Dignam succeeds Mark Newman, who resigned from his officer and director positions with the Company, also effective as of March 22, 2024. Prior to the appointment

View on Read The Filing